uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Amifampridine SERB
Authorised
Human
Details
EMA number
EMEA/H/C/005839
ATC code
N07XX05
Authorisation
19 May 2022
Revision
-
EMA page
Therapeutic indication
Symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
MeSH:
Myasthenia Gravis
Group:
Other nervous system drugs
Active substances
amifampridine phosphate
Marketing Authorisation Holder
SERB SA
MAH
Timeline
Filter by authority:
EMA
Amifampridine SERB authorised
19 May 2022
authorised
regulatory
Amifampridine SERB | uMedical